Lifeway: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Nov. 12, 2026, Lifeway (NASDAQ:LWAY) announced record quarterly net sales of $67.8 million. The maker of kefir, a fermented milk drink rich in probiotics, is managing high customer demand alongside factory bottlenecks and input cost inflation. Three key takeaways stand out for long-term investors. High customer demand forced management to put existing accounts on allocation, restricting orders as factory output reached its physical ceiling. Expanding the Waukesha, Wisconsin facility will double bottling capacity and clear customer backlogs starting in early 2027. Milk prices remained elevated after a 26% surge from Q1 to Q2, pushing third-quarter gross margin down to 18%. Management is implementing rolling price increases across retail partners to rebuild profit margins toward historical levels above 25%. Continue reading